Pappas Ventures is the famous VC, which was founded in 1994. The main department of described VC is located in the Durham. The venture was found in North America in United States.
The usual cause for the fund is to invest in rounds with 5-6 partakers. Despite the Pappas Ventures, startups are often financed by Asset Management Ventures (AMV), Domain Associates, Frazier Healthcare Partners. The meaningful sponsors for the fund in investment in the same round are New Enterprise Associates, Morningside Group, Kleiner Perkins. In the next rounds fund is usually obtained by Domain Associates, New Enterprise Associates, Kleiner Perkins.
This Pappas Ventures works on 17 percentage points more the average amount of lead investments comparing to the other organizations. The top amount of exits for fund were in 2010. The top activity for fund was in 2010. The fund is constantly included in 2-6 investment rounds annually. The average startup value when the investment from Pappas Ventures is 100-500 millions dollars. The common things for fund are deals in the range of 10 - 50 millions dollars. The real fund results show that this VC is 11 percentage points less often commits exit comparing to other companies.
We also calculated 4 valuable employees in our database.
Moreover, a startup needs to be at the age of 4-5 years to get the investment from the fund. Among the most popular fund investment industries, there are Health Care, Medical. For fund there is a match between the country of its foundation and the country of its the most frequent investments - United States. Among the various public portfolio startups of the fund, we may underline TESARO, Afferent Pharmaceuticals, CardioDx The fund has exact preference in a number of founders of portfolio startups. In case when startup counts 5+ of the founder, the chance for it to get the investment is meager.
Related Funds
Funds with similar focus
Fund Name | Location |
AAIC Ventures | China, Hong Kong, Hong Kong Island |
Avellinia Capital | England, London, United Kingdom |
Beijing Film | Beijing, Beijing, China |
CreativeEurope MEDIA | Lithuania, Vilniaus Apskritis, Vilnius |
Danish Microfinance Partners | - |
DSP BlacRock India Tiger Fund | - |
First Imagine! Ventures | England, London, United Kingdom |
Home Inn | China, Shanghai |
InterVest Co. | Seoul, Seoul-t'ukpyolsi, South Korea |
MDA | Boston, Massachusetts, United States |
NJF Capital | England, London, United Kingdom |
Nummorum | Distrito Federal, Mexico, Mexico City |
Qunda Technology | China, Guangdong, Shenzhen |
ROBOT PAYMENT | Japan, Tokyo |
Rugged VC | - |
S-Pool | Japan, Tokyo |
Sun Pharma | India, Maharashtra, Mumbai |
Taihe Youdian | China, Fujian, Xiamen |
Notable deals
Company | Industry | Round Size | Date | Investors | Location |
VelosBio | $58M | 01 Oct 2018 | - | ||
Kezar Life Sciences | $50M | 25 Jul 2017 | South San Francisco, California, United States | ||
Evidation Health | $3M | 11 Oct 2016 | California, United States | ||
Rotation Medical | $12M | 16 Aug 2016 | Minnesota, United States | ||
Milestone Pharmaceuticals | $17M | 15 Jun 2015 | Montreal, Quebec, Canada | ||
Balance Therapeutics | $18M | 19 Mar 2015 | California, United States | ||
Aura Biosciences | $21M | 05 Mar 2015 | Cambridge, Massachusetts, United States | ||
CoLucid Pharmaceuticals | $37M | 13 Jan 2015 | Durham, North Carolina, United States | ||
Rotation Medical | $27M | 02 Jul 2014 | Minnesota, United States |
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Latest deals
Company | Industry | Round Size | Date | Investors | Location |
VelosBio | $58M | 01 Oct 2018 | - | ||
Kezar Life Sciences | $50M | 25 Jul 2017 | South San Francisco, California, United States | ||
Evidation Health | $3M | 11 Oct 2016 | California, United States | ||
Rotation Medical | $12M | 16 Aug 2016 | Minnesota, United States | ||
Milestone Pharmaceuticals | $17M | 15 Jun 2015 | Montreal, Quebec, Canada | ||
Balance Therapeutics | $18M | 19 Mar 2015 | California, United States | ||
Aura Biosciences | $21M | 05 Mar 2015 | Cambridge, Massachusetts, United States | ||
CoLucid Pharmaceuticals | $37M | 13 Jan 2015 | Durham, North Carolina, United States | ||
Rotation Medical | $27M | 02 Jul 2014 | Minnesota, United States |